The covid wave this winter is less severe compared with previous years, with hospitalization rates down and wastewater levels ...

The 30-day risks of hospitalization were 17.5%, 15.9%, and 14.4% for COVID, influenza, and RSV, respectively, during the 2022 ...

Some in the medical community say that antiviral treatments are underutilized and could help more people recover from ...

RSV and whooping cough are all on the decline in Minnesota. The bad news? Norovirus case counts have climbed this month, and ...

The number of local emergency department visits for respiratory illnesses in Broome County has changed since the beginning of ...

Axios Visuals The flu is once again colliding with COVID and RSV in Virginia — but this time, it's happening while norovirus cases are well above normal levels nationwide. Why it matters: The result ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...

On Friday, a campus that is typically full of life now stands quiet. Not a student was in sight at St. Andrew’s Episcopal ...

As a bird flu outbreak escalates across the United States., the Trump administration has paused the release of key public ...

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...

and 0.9% for COVID versus 0.7% for both flu and RSV during the 2023-2024 season, reported Kristina L. Bajema, MD, of the Veterans Affairs Portland Health Care System in Oregon, and colleagues.